+ All Categories
Home > Documents > THE STORY OF OUR FIRST FIVE YEARS - Zoetis, the largest global animal … · Mid-Size Employers...

THE STORY OF OUR FIRST FIVE YEARS - Zoetis, the largest global animal … · Mid-Size Employers...

Date post: 25-Jun-2020
Category:
Upload: others
View: 10 times
Download: 0 times
Share this document with a friend
1
WORLD VETERINARY DAY 5K IN CHINA 100 Best Companies Working Mother Magazine (2014, 2015, 2016, 2017) Best Companies to Work For In Brazil Você S/A Magazine (2015, 2017) America’s Best Mid-Size Employers Forbes (2016, 2017) 1000 Best and Biggest Companies in Brazil EXAME Magazine (2016, 2017) Best New Product and Best New Product Portfolio Awards Animal Pharm Innovation Awards (2016) THE STORY OF OUR FIRST FIVE YEARS 2013 LAUNCH & CELEBRATION Celebrated our IPO, becoming the world's leading publicly traded animal health company on February 1, 2013 Joined the S&P 500 Key product approvals: Apoquel® (FDA & EMA) Rui Lan An™ (China) Defined our Core Beliefs as the foundation of our new culture 2015 DEFINING OUR PATH FORWARD Launched Simplification and Efficiency initiative Opened new R&D center in Beijing and manufacturing site in Suzhou, China Key Acquisitions: Abbott animal health assets KL Products, a leader in automation systems for the poultry industry PHARMAQ, an industry leader in vaccines for farmed fish 2016 DELIVERING RESULTS AND DRIVING GROWTH Acquired Scandinavian Micro Biodevices -- a pioneer in developing and manufacturing microfluidic “lab on a chip” diagnostic analyzers and tests for veterinary point-of-care services Global headquarters in Parsippany, NJ International headquarters in Dublin, Ireland Opened new headquarters buildings: Key Product Approvals: Simparica® (sarolaner) Chewables (FDA, European Commission) Vanguard® vaccine franchise expansion for dogs (USDA) - Vanguard B oral vaccine - 3 new Vanguard Rapid Resp Intranasal vaccines - Vanguard CR Lyme vaccine Cytopoint® (USDA) 2017 INVESTING IN GROWTH FOR THE LONG TERM Debuted our first-ever national advertising direct-to-consumer campaigns in the U.S. and Brazil Key Product Approvals: Stronghold Plus (European Commission) Key Acquisitions: Nexvet, a clinical-stage company focused on innovation in monoclonal antibody therapies for companion animals Acquired full ownership of Zoetis Jilin operations from joint venture partner in China Evolved Our Supply Network Strategy with investments in: Rathdrum, Ireland; Kalamazoo, Michigan; Ontario, Canada; Charles City, Iowa; Suzhou, China; Jilin, China; and Lincoln, Nebraska ACROSS THE YEARS AWARDS & RECOGNITIONS FINANCIAL RESULTS Grew revenue in-line with or faster than the market Grew adjusted net income faster than sales around the world living our Core Beliefs 9,000 COLLEAGUES 2014 ONE YEAR STRONG: STANDING UP ZOETIS Launched The Zone, Our company’s Intranet site for all colleagues Key product approvals: • Received conditional license for PEDv vaccine for pigs in the U.S. INNOVATION product approvals (new products & lifecycle innovations) 1,000+ Announced program to build better animal health in Africa: African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative © Bill & Melinda Gates Foundation/ Sarah Elliot CARING FOR OUR CUSTOMERS & COMMUNITIES BEYONDBLUE PARTNERSHIP IN AUSTRALIA Public company firsts! • Annual Report • Annual Meeting of Shareholders • Investor Day ZOETIS FOR SHELTERS PROGRAM IN THE U.S. K-9 COURAGE PROGRAM IN THE U.S. DISASTER RELIEF SUPPORT ACROSS THE WORLD REVOLUTION DOGRUN IN ARGENTINA
Transcript
Page 1: THE STORY OF OUR FIRST FIVE YEARS - Zoetis, the largest global animal … · Mid-Size Employers Forbes (2016, 2017) 1000 Best and Biggest Companies in Brazil EXAME Magazine (2016,

WORLD VETERINARY DAY 5K IN CHINA

100 Best Companies Working Mother Magazine (2014, 2015, 2016, 2017)

Best Companies to Work For In Brazil Você S/A Magazine (2015, 2017)

America’s Best Mid-Size Employers Forbes(2016, 2017)

1000 Best and Biggest Companies in Brazil EXAME Magazine(2016, 2017)

Best New Product and Best New Product Portfolio Awards Animal Pharm Innovation Awards (2016)

THE STORY OF OUR FIRST FIVE YEARS

2013LAUNCH & CELEBRATION

Celebrated our IPO, becoming the world's

leading publicly traded animal health

company on February 1, 2013

Joined the S&P 500

Key product approvals:

• Apoquel® (FDA & EMA)

• Rui Lan An™ (China)

Defined our Core Beliefs as the foundation of our new culture

2015DEFINING OUR PATH FORWARD

Launched Simplification and E�ciency initiative

Opened new R&D center inBeijing and manufacturing

site in Suzhou, China

Key Acquisitions:

• Abbott animal health assets

• KL Products, a leader in automation systems for the poultry industry

• PHARMAQ, an industry leader in vaccines for farmed fish

2016DELIVERING RESULTS AND DRIVING GROWTH

Acquired Scandinavian Micro Biodevices -- a pioneer in developing

and manufacturing microfluidic “lab on a chip” diagnostic analyzers

and tests for veterinary point-of-care services

Global headquarters in Parsippany, NJ

International headquarters in Dublin, Ireland

Opened new headquarters buildings:

Key Product Approvals:

• Simparica® (sarolaner) Chewables (FDA, European Commission)

• Vanguard® vaccine franchise expansion for dogs (USDA) - Vanguard B oral vaccine - 3 new Vanguard Rapid Resp Intranasal vaccines - Vanguard CR Lyme vaccine

• Cytopoint® (USDA)

2017INVESTING IN GROWTH FOR THE LONG TERM

Debuted our first-ever nationaladvertising direct-to-consumercampaigns in the U.S. and Brazil

Key Product Approvals:

• Stronghold Plus (European Commission)

Key Acquisitions:

• Nexvet, a clinical-stage company focused on innovation in monoclonal antibody therapies for companion animals

• Acquired full ownership of Zoetis Jilin operations from joint venture partner in China

Evolved Our Supply Network Strategy with investments in:

• Rathdrum, Ireland; Kalamazoo, Michigan; Ontario, Canada; Charles City, Iowa; Suzhou, China; Jilin, China; and Lincoln, Nebraska

ACROSS THE YEARS

AWARDS &RECOGNITIONS

FINANCIALRESULTS

Grew revenue in-line with or faster than the market

Grew adjusted net income faster than sales

around the world living our Core Beliefs

9,000 COLLEAGUES

2014ONE YEAR STRONG: STANDING UP ZOETIS

Launched The Zone, Our company’s Intranet site for all colleagues

Key product approvals:

• Received conditional license for PEDv vaccine for pigs in the U.S.

INNOVATION

product approvals (new products &

lifecycle innovations)

1,000+

Announced programto build better animal

health in Africa:African LivestockProductivity and

Health Advancement(A.L.P.H.A.) initiative© Bill & Melinda Gates Foundation/

Sarah Elliot

CARING FOR OUR CUSTOMERS & COMMUNITIES

BEYONDBLUE PARTNERSHIP IN AUSTRALIA

Public company firsts!

• Annual Report

• Annual Meeting of Shareholders

• Investor Day

ZOETIS FOR SHELTERS PROGRAM IN THE U.S.

K-9 COURAGE PROGRAM IN THE U.S.

DISASTER RELIEF SUPPORT ACROSS THE WORLD

REVOLUTION DOGRUN IN ARGENTINA

Recommended